Development of a monoclonal anti-ADAMTS-5 antibody that specifically blocks the interaction with LRP1.

Santamaria S., Fedorov O., McCafferty J., Murphy G., Dudhia J., Nagase H., Yamamoto K.

The potent aggrecanase ADAMTS-5 is constitutively secreted by chondrocytes, but it is rapidly endocytosed in normal cartilage via the cell surface endocytic receptor LRP1. Therefore it is difficult to detect the total ADAMTS-5 activity produced. In this study, we isolated a monoclonal anti-ADAMTS-5 antibody 1B7 that blocks LRP1-mediated internalization without affecting the aggrecanolytic activity. Addition of 1B7 to cultured human chondrocytes revealed the full aggrecanolytic activity of ADAMTS-5 generated by the cells. 1B7 is a useful tool to estimate the ADAMTS-5 activity and to identify its potential roles in the tissues.

DOI

10.1080/19420862.2017.1304341

Type

Journal article

Journal

Mabs

Publication Date

05/2017

Volume

9

Pages

595 - 602

Keywords

Aggrecanase, cartilage, endocytosis, extracellular matrix, proteoglycanase, ADAMTS5 Protein, Animals, Antibodies, Monoclonal, Murine-Derived, Cattle, Chondrocytes, Humans, Low Density Lipoprotein Receptor-Related Protein-1, Mice

Permalink Original publication